Hirano Takashi, Kodama Satoru, Moriyama Munehito, Kawano Toshiaki, Suzuki Masashi
Department of Otolaryngology, Faculty of Medicine, Oita University, Hasama-machi, Oita 8795593, Japan.
Int J Pediatr Otorhinolaryngol. 2009 Dec;73(12):1657-65. doi: 10.1016/j.ijporl.2009.08.015. Epub 2009 Sep 17.
Acute otitis media (AOM) is one of the most common infectious diseases in children. Nontypeable Haemophilus influenzae (NTHi) is considered a major pathogen in AOM. Current treatment options depend mainly on the use of antibiotics, thus developing vaccines to prevent this disease is an urgent goal for public health. Outer membrane proteins (OMPs) are promising candidate targets for vaccination against NTHi.
We used C3H/HeJ (Toll-like receptor 4 [TLR4]-mutant) mice, which arose spontaneously and have a non-functional TLR4 protein, and normal wild-type (WT) C3H/HeN mice. These mice were immunized intranasally with OMP from NTHi to investigate the mechanism of acquired immunity via TLR4. We examined the kinetics of mucosal and systemic antibody secretion and the migration of antibody producing lymphocytes to the mucosa in both strains during the course of intranasal immunization.
The mucosal and systemic immune responses against OMP from NTHi were elicited in both TLR4-mutant and WT mice. However, the mucosal IgA, and systemic IgG, and Th1 immune responses in WT mice were stronger than those in TLR4-mutant mice.
TLR4 plays an important role in relation to Th1 function for optimal development of the acquired immune responses to OMP administered intranasally. The variety of immune responses via TLR4 expression needs to be taken into consideration of individual vaccinations to prevent AOM.
急性中耳炎(AOM)是儿童最常见的传染病之一。非分型流感嗜血杆菌(NTHi)被认为是AOM的主要病原体。目前的治疗选择主要依赖于抗生素的使用,因此开发预防这种疾病的疫苗是公共卫生的紧迫目标。外膜蛋白(OMPs)是针对NTHi疫苗接种的有前景的候选靶点。
我们使用自发产生且具有无功能TLR4蛋白的C3H/HeJ(Toll样受体4 [TLR4]突变体)小鼠和正常野生型(WT)C3H/HeN小鼠。这些小鼠通过鼻内接种NTHi的OMP进行免疫,以研究通过TLR4获得性免疫的机制。我们在鼻内免疫过程中检查了两种品系小鼠黏膜和全身抗体分泌的动力学以及产生抗体的淋巴细胞向黏膜的迁移情况。
TLR4突变体小鼠和WT小鼠均引发了针对NTHi的OMP的黏膜和全身免疫反应。然而,WT小鼠的黏膜IgA、全身IgG和Th1免疫反应比TLR4突变体小鼠更强。
TLR4在鼻内给予OMP后获得性免疫反应的最佳发育中,在Th1功能方面发挥重要作用。在预防AOM的个体疫苗接种中,需要考虑通过TLR4表达产生的多种免疫反应。